Concepedia

Publication | Open Access

Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II Trial

DOIFull Paper Access

238

Citations

22

References

2016

Year

Nick Pavlakis, Katrin Marie Sjoquist, Andrew Martin, Eric Tsobanis, Sonia Yip, Yoon‐Koo Kang, Yung‐Jue Bang, Thierry Alcindor, Christopher J. O’Callaghan, Margot J. Burnell,
Journal of Clinical Oncology

Abstract

In this phase II trial, regorafenib was effective in prolonging PFS in refractory advanced gastric adenocarcinoma. Regional differences were found, but regorafenib was effective in both regional groups. A phase III trial is planned.

References

YearCitations

Page 1